
Aditi Dutt
Examiner (ID: 15807, Phone: (571)272-9037 , Office: P/1649 )
| Most Active Art Unit | 1649 |
| Art Unit(s) | 1649, 1675 |
| Total Applications | 622 |
| Issued Applications | 221 |
| Pending Applications | 78 |
| Abandoned Applications | 328 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19550955
[patent_doc_number] => 12134651
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-11-05
[patent_title] => Anti-Ryk antibodies and methods of using the same
[patent_app_type] => utility
[patent_app_number] => 17/127913
[patent_app_country] => US
[patent_app_date] => 2020-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 45
[patent_figures_cnt] => 98
[patent_no_of_words] => 32115
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17127913
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/127913 | Anti-Ryk antibodies and methods of using the same | Dec 17, 2020 | Issued |
Array
(
[id] => 16915879
[patent_doc_number] => 20210188971
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-24
[patent_title] => MONOCLONAL ANTIBODY FUSIONS
[patent_app_type] => utility
[patent_app_number] => 17/127810
[patent_app_country] => US
[patent_app_date] => 2020-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24159
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17127810
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/127810 | MONOCLONAL ANTIBODY FUSIONS | Dec 17, 2020 | Pending |
Array
(
[id] => 16806134
[patent_doc_number] => 20210128687
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-06
[patent_title] => METHOD OF EFFECTING NEUROPROTECTION USING SOLUBLE NEUREGULIN ISOFORMS
[patent_app_type] => utility
[patent_app_number] => 17/126351
[patent_app_country] => US
[patent_app_date] => 2020-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11276
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17126351
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/126351 | METHOD OF EFFECTING NEUROPROTECTION USING SOLUBLE NEUREGULIN ISOFORMS | Dec 17, 2020 | Abandoned |
Array
(
[id] => 17143010
[patent_doc_number] => 20210311023
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-07
[patent_title] => CHEMICAL COCKTAIL FOR INDUCING SENESCENCE IN HUMAN NEURONS TO PROMOTE DISEASE MODELING AND DRUG DISCOVERY
[patent_app_type] => utility
[patent_app_number] => 17/117096
[patent_app_country] => US
[patent_app_date] => 2020-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12147
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17117096
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/117096 | CHEMICAL COCKTAIL FOR INDUCING SENESCENCE IN HUMAN NEURONS TO PROMOTE DISEASE MODELING AND DRUG DISCOVERY | Dec 8, 2020 | Pending |
Array
(
[id] => 16948115
[patent_doc_number] => 20210206806
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-08
[patent_title] => PEPTIDIC LINKER WITH REDUCED POST-TRANSLATIONAL MODIFICATION
[patent_app_type] => utility
[patent_app_number] => 17/111820
[patent_app_country] => US
[patent_app_date] => 2020-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17132
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 165
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17111820
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/111820 | PEPTIDIC LINKER WITH REDUCED POST-TRANSLATIONAL MODIFICATION | Dec 3, 2020 | Pending |
Array
(
[id] => 17445369
[patent_doc_number] => 20220065874
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-03
[patent_title] => METHODS FOR THE IDENTIFICATION, ASSESSMENT, PREVENTION, AND TREATMENT OF NEUROLOGICAL DISORDERS AND DISEASES
[patent_app_type] => utility
[patent_app_number] => 17/013974
[patent_app_country] => US
[patent_app_date] => 2020-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6803
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17013974
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/013974 | METHODS FOR THE IDENTIFICATION, ASSESSMENT, PREVENTION, AND TREATMENT OF NEUROLOGICAL DISORDERS AND DISEASES | Sep 7, 2020 | Abandoned |
Array
(
[id] => 19839068
[patent_doc_number] => 12251423
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-03-18
[patent_title] => Method of effecting neuroprotection using soluble neuregulin isoforms
[patent_app_type] => utility
[patent_app_number] => 17/012159
[patent_app_country] => US
[patent_app_date] => 2020-09-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 12
[patent_no_of_words] => 11305
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17012159
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/012159 | Method of effecting neuroprotection using soluble neuregulin isoforms | Sep 3, 2020 | Issued |
Array
(
[id] => 16398789
[patent_doc_number] => 20200339647
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-29
[patent_title] => INHIBITOR OF ASTROCYTE TNF ALPHA FOR USE IN THE TREATMENT OF NEUROLOGICAL DISEASES
[patent_app_type] => utility
[patent_app_number] => 16/928735
[patent_app_country] => US
[patent_app_date] => 2020-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7206
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16928735
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/928735 | INHIBITOR OF ASTROCYTE TNF ALPHA FOR USE IN THE TREATMENT OF NEUROLOGICAL DISEASES | Jul 13, 2020 | Abandoned |
Array
(
[id] => 18225496
[patent_doc_number] => 20230064490
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-02
[patent_title] => FLUORESCENT PROTEIN BIOSENSOR FOR DETECTION OF KINASE ACTIVITY
[patent_app_type] => utility
[patent_app_number] => 16/923927
[patent_app_country] => US
[patent_app_date] => 2020-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14233
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16923927
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/923927 | FLUORESCENT PROTEIN BIOSENSOR FOR DETECTION OF KINASE ACTIVITY | Jul 7, 2020 | Abandoned |
Array
(
[id] => 16791724
[patent_doc_number] => 20210121541
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-29
[patent_title] => CGRP Antagonists and Clostridial Derivatives for the Treatment of Neuropsychiatric and Neurological Disorders
[patent_app_type] => utility
[patent_app_number] => 16/921502
[patent_app_country] => US
[patent_app_date] => 2020-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15216
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16921502
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/921502 | CGRP Antagonists and Clostridial Derivatives for the Treatment of Neuropsychiatric and Neurological Disorders | Jul 5, 2020 | Abandoned |
Array
(
[id] => 16514150
[patent_doc_number] => 20200393408
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-17
[patent_title] => ALLERGY ANTIGEN AND EPITOPE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/899643
[patent_app_country] => US
[patent_app_date] => 2020-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38555
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 1144
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16899643
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/899643 | ALLERGY ANTIGEN AND EPITOPE THEREOF | Jun 11, 2020 | Abandoned |
Array
(
[id] => 17750853
[patent_doc_number] => 20220229058
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-21
[patent_title] => NOROVIRUS-BINDING PEPTIDE
[patent_app_type] => utility
[patent_app_number] => 17/613310
[patent_app_country] => US
[patent_app_date] => 2020-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10111
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17613310
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/613310 | Norovirus-binding peptide | May 27, 2020 | Issued |
Array
(
[id] => 16726465
[patent_doc_number] => 20210093612
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-01
[patent_title] => SYSTEMS AND METHODS TO TREAT PAIN LOCALLY
[patent_app_type] => utility
[patent_app_number] => 16/874984
[patent_app_country] => US
[patent_app_date] => 2020-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7574
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16874984
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/874984 | SYSTEMS AND METHODS TO TREAT PAIN LOCALLY | May 14, 2020 | Abandoned |
Array
(
[id] => 16466828
[patent_doc_number] => 20200368365
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-26
[patent_title] => COMPOUNDS AND COMPOSITIONS FOR TARGETING BRAIN INJURIES AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/859893
[patent_app_country] => US
[patent_app_date] => 2020-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35080
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16859893
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/859893 | Compounds and compositions for targeting brain injuries and methods of use thereof | Apr 26, 2020 | Issued |
Array
(
[id] => 18013339
[patent_doc_number] => 11505621
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-11-22
[patent_title] => H1.0K180me2 antibodies, methods of making and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/857091
[patent_app_country] => US
[patent_app_date] => 2020-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 33
[patent_no_of_words] => 23350
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16857091
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/857091 | H1.0K180me2 antibodies, methods of making and uses thereof | Apr 22, 2020 | Issued |
Array
(
[id] => 16238655
[patent_doc_number] => 20200255889
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-13
[patent_title] => SEROLOGICAL ASSAY FOR DETECTION OF EXPOSURE TO AND INFECTION BY TICK-BORNE PATHOGENS
[patent_app_type] => utility
[patent_app_number] => 16/828483
[patent_app_country] => US
[patent_app_date] => 2020-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20571
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16828483
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/828483 | SEROLOGICAL ASSAY FOR DETECTION OF EXPOSURE TO AND INFECTION BY TICK-BORNE PATHOGENS | Mar 23, 2020 | Pending |
Array
(
[id] => 16175500
[patent_doc_number] => 20200222468
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-16
[patent_title] => IN VITRO MODEL FOR NEURONAL DEATH
[patent_app_type] => utility
[patent_app_number] => 16/826981
[patent_app_country] => US
[patent_app_date] => 2020-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7613
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16826981
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/826981 | In vitro model for neuronal death | Mar 22, 2020 | Issued |
Array
(
[id] => 17611864
[patent_doc_number] => 20220154143
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-19
[patent_title] => Culture Method for Head and Neck Organoids
[patent_app_type] => utility
[patent_app_number] => 17/437477
[patent_app_country] => US
[patent_app_date] => 2020-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31924
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17437477
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/437477 | Culture Method for Head and Neck Organoids | Mar 15, 2020 | Pending |
Array
(
[id] => 15927687
[patent_doc_number] => 20200155477
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-21
[patent_title] => CLADRIBINE REGIMEN FOR TREATING MULTIPLE SCLEROSIS
[patent_app_type] => utility
[patent_app_number] => 16/782094
[patent_app_country] => US
[patent_app_date] => 2020-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22285
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16782094
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/782094 | Cladribine regimen for treating multiple sclerosis | Feb 4, 2020 | Issued |
| 16/727131 | MODULATING VENULENESS OF ENDOTHELIAL CELLS | Dec 25, 2019 | Abandoned |